The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.80
Bid: 38.80
Ask: 39.55
Change: 0.40 (1.04%)
Spread: 0.75 (1.933%)
Open: 38.65
High: 38.80
Low: 38.65
Prev. Close: 38.40
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

Thu, 04th Mar 2021 11:42

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Futura Medical, up 22% at 20.08 pence, 12-month range 7.16p-24.49p. The pharmaceutical company says it has entered into financing transactions with HT Riverwood Multi-Growth Fund which will provide the company with up to GBP2 million in cash, GBP1.5 million of which has been received.

----------

Franchise Brands, up 7.7% at 109.30p, 12-month range 81p-136.65p. Says it saw a resilient performance through lockdowns and a robust recovery in second half. For 2020, revenue increases by 12% to GBP49.3 million from GBP44.0 million in 2019 and pretax profit increases to GBP3.7 million from GBP3.3 million. Franchise Brands ups final dividend to 0.80p per share from 0.65p paid in 2019.

----------

ThinkSmart, up 6.7% at 77.9p, 12-month range 12p-91.5p. The digital payments business posts rise in interim earnings. For six months to December 31, pretax profit surges to GBP53.7 million from GBP16.0 million after financial instruments gains. ThinkSmart pays 3.4p per share special dividend and capital return in December.

----------

AIM - LOSERS

----------

MediaZest, down 16% at 0.080p, 12-month range 0.01p-0.18p. The audio-visual company says financial results for the eighteen-month period were affected substantially by the Covid-19 pandemic, with reduction in revenue particularly during the first UK lockdown. Revenue GP3.1 million, down from GBP3.3 million year before and swings to GBP478,000 pretax loss from GBP6,000 profit.

----------

Angle, down 9.7% at 79.30p, 12-month range 37.15p-98p. The liquid biopsy company says it has received response from US Food & Drug Administration after requesting clearance for its Parsortix treatment. Says FDA has indicated its review processes for non Covid-19 devices are currently slower than usual due to pandemic priorities. Notes that FDA processes are outside the company's control and it is continuing to expedite all aspects of the process which are under its control in line with previously advised timescales.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Apr 2022 18:03

TRADING UPDATES: Billington faces headwinds; Immotion plans spin-off

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
23 Mar 2022 15:35

Futura signs up Korean partner for erection gel product

(Sharecast News) - Pharmaceutical and drug delivery technology developer Futura Medical has entered into a licensing agreement with Menarini Korea, it announced on Wednesday, for the exclusive rights to commercialise the company's topical gel-based erectile dysfunction treatment MED3000 in South Korea.

Read more
23 Mar 2022 11:50

Futura Medical shares rise on licensing deal with Menarini Korea

(Alliance News) - Futura Medical PLC shares jumped on Wednesday after the company said it has entered a licensing agreement with A Menarini Korea Ltd or the exclusive rights to commercialise its MED3000 treatment in South Korea.

Read more
20 Dec 2021 21:59

TRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist

TRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist

Read more
20 Dec 2021 10:46

Futura Medical makes good progress with topical erection gel treatment

(Sharecast News) - Futura Medical updated the market on regulatory and commercial progress for 'MED3000', its topical gel formulation for the treatment of erectile dysfunction, on Monday.

Read more
29 Oct 2021 15:57

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

Read more
8 Oct 2021 13:51

EXECUTIVE CHANGES: WH Ireland hires new CFO; Grubhub founder exits JET

EXECUTIVE CHANGES: WH Ireland hires new CFO; Grubhub founder exits JET

Read more
29 Sep 2021 13:22

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

Read more
27 Sep 2021 16:54

Futura Medical inks licensing deal with Labtec Pharma

(Sharecast News) - Transdermal drug delivery technology company Futura Medical has entered into a licensing agreement with Labatec Pharma, a Switzerland-based specialty pharma company focussed on commercialisation in the Europe and Middle East and North Africa (MENA) regions, it announced on Monday.

Read more
27 Sep 2021 12:01

IN BRIEF: Futura Medical teams with Labatec to commercialise MED3000

IN BRIEF: Futura Medical teams with Labatec to commercialise MED3000

Read more
22 Sep 2021 17:53

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
15 Sep 2021 20:23

IN BRIEF: Futura progressing US regulatory submission for MED3000

IN BRIEF: Futura progressing US regulatory submission for MED3000

Read more
1 Sep 2021 20:56

TRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners

TRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners

Read more
31 Aug 2021 15:08

Futura enters erection gel licensing deal with M8

(Sharecast News) - Futura Medical has entered into a licensing agreement with M8 Pharmaceuticals, a specialty biopharmaceutical company focused on commercialisation in Latin America, for the rights to exclusively develop and commercialise its topical, gel-based erectile dysfunction (ED) treatment MED3000 in Brazil and Mexico, it announced on Tuesday.

Read more
19 Jul 2021 19:13

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.